According to the latest research analysis,the global market for Menopause Hormonal Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Menopause Hormonal Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Menopause Hormonal Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Table segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital Pharmacies has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Menopause Hormonal Treatment include Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Cipla and Teva Pharmaceutical Industries, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Menopause Hormonal Treatment.
Data-Driven Insights: Highlights from Our Report
(1) Global Menopause Hormonal Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Menopause Hormonal Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Menopause Hormonal Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Menopause Hormonal Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Menopause Hormonal Treatment segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Menopause Hormonal Treatment, capacity, production and trends.
(7) Menopause Hormonal Treatment industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Table
Patch
Spray
Others
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Understanding Market Segments by Key Players: Insights and Opportunities
Merck
Novartis
Novo Nordisk
Pfizer
Allergan
Emcure Pharmaceuticals
Eli Lilly And Company
Cipla
Teva Pharmaceutical Industries
Pure Encapsulations, Inc.
Bayer
Theramex
AbbVie
1 Market Overview
1.1 Menopause Hormonal Treatment Definition
1.2 Global Menopause Hormonal Treatment Market Size and Forecast
1.2.1 By Revenue, Global Menopause Hormonal Treatment Market Size, 2018-2029
1.2.2 By Sales Volume, Global Menopause Hormonal Treatment Market Size, 2018-2029
1.2.3 Global Menopause Hormonal Treatment Price Trend, 2018-2029
1.3 China Menopause Hormonal Treatment Market Size and Forecast
1.3.1 By Revenue, China Menopause Hormonal Treatment Market Size, 2018-2029
1.3.2 By Sales Volume, China Menopause Hormonal Treatment Market Size, 2018-2029
1.3.3 China Menopause Hormonal Treatment Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Menopause Hormonal Treatment Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Menopause Hormonal Treatment Share in Global Market, 2018-2029
1.4.3 Menopause Hormonal Treatment Market Size: China VS Global, 2018-2029
1.5 Menopause Hormonal Treatment Market Dynamics
1.5.1 Menopause Hormonal Treatment Market Drivers
1.5.2 Menopause Hormonal Treatment Market Restraints
1.5.3 Menopause Hormonal Treatment Industry Trends
1.5.4 Menopause Hormonal Treatment Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Menopause Hormonal Treatment Revenue by Company, 2018-2023
2.2 Global Menopause Hormonal Treatment Sales Volume by Company, 2018-2023
2.3 Global Menopause Hormonal Treatment Price by Company, 2018-2023
2.4 Global Menopause Hormonal Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Menopause Hormonal Treatment Concentration Ratio
2.6 Global Menopause Hormonal Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Menopause Hormonal Treatment Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Menopause Hormonal Treatment Revenue by Company, 2018-2023
3.2 China Menopause Hormonal Treatment Sales Volume by Company, 2018-2023
3.3 China Menopause Hormonal Treatment Menopause Hormonal Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Menopause Hormonal Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Menopause Hormonal Treatment Domestic VS Export
3.6 China Market, Menopause Hormonal Treatment Import & Export
3.6.1 China Market, Menopause Hormonal Treatment Import & Export, 2018-2029
3.6.2 China Menopause Hormonal Treatment Import & Export Trends
3.6.3 Main Sources of China Menopause Hormonal Treatment Import
3.6.4 Export Destination of China Menopause Hormonal Treatment
4 Menopause Hormonal Treatment Production by Region
4.1 Global Menopause Hormonal Treatment Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Menopause Hormonal Treatment Manufacturers
4.3 Global Major Manufacturers, Menopause Hormonal Treatment Capacity Expansion and Future Plans
4.4 Global Menopause Hormonal Treatment Capacity by Region
4.5 Global Menopause Hormonal Treatment Production by Region
4.5.1 Global Menopause Hormonal Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Menopause Hormonal Treatment Production by Region, 2018-2023
4.5.3 Global Menopause Hormonal Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Menopause Hormonal Treatment Industry Chain
5.2 Menopause Hormonal Treatment Upstream Analysis
5.2.1 Menopause Hormonal Treatment Core Raw Materials
5.2.2 Main Manufacturers of Menopause Hormonal Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Menopause Hormonal Treatment Production Mode
5.6 Menopause Hormonal Treatment Procurement Model
5.7 Menopause Hormonal Treatment Industry Sales Model and Sales Channels
5.7.1 Menopause Hormonal Treatment Sales Model
5.7.2 Menopause Hormonal Treatment Typical Distributors
6 Sights by Type
6.1 Menopause Hormonal Treatment Classification
6.1.1 Table
6.1.2 Patch
6.1.3 Spray
6.1.4 Others
6.2 By Type, Global Menopause Hormonal Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Menopause Hormonal Treatment Revenue, 2018-2029
6.4 By Type, Global Menopause Hormonal Treatment Sales Volume, 2018-2029
6.5 By Type, Global Menopause Hormonal Treatment Price, 2018-2029
7 Sights by Application
7.1 Menopause Hormonal Treatment Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Menopause Hormonal Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Menopause Hormonal Treatment Revenue, 2018-2029
7.4 By Application, Global Menopause Hormonal Treatment Sales Volume, 2018-2029
7.5 By Application, Global Menopause Hormonal Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Menopause Hormonal Treatment Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Menopause Hormonal Treatment Revenue, 2018-2029
8.3 By Region, Global Menopause Hormonal Treatment Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Menopause Hormonal Treatment Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Menopause Hormonal Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Menopause Hormonal Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Menopause Hormonal Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Menopause Hormonal Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Menopause Hormonal Treatment Market Size Market Share
8.7 South America
8.7.1 South America Menopause Hormonal Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Menopause Hormonal Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Menopause Hormonal Treatment Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Menopause Hormonal Treatment Revenue, 2018-2029
9.3 By Country, Global Menopause Hormonal Treatment Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Menopause Hormonal Treatment Market Size, 2018-2029
9.4.2 By Company, U.S. Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Menopause Hormonal Treatment Market Size, 2018-2029
9.5.2 By Company, Europe Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.5.3 By Type, Europe Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Menopause Hormonal Treatment Market Size, 2018-2029
9.6.2 By Company, China Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.6.3 By Type, China Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Menopause Hormonal Treatment Market Size, 2018-2029
9.7.2 By Company, Japan Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.7.3 By Type, Japan Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Menopause Hormonal Treatment Market Size, 2018-2029
9.8.2 By Company, South Korea Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Menopause Hormonal Treatment Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Menopause Hormonal Treatment Market Size, 2018-2029
9.10.2 By Company, India Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.10.3 By Type, India Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Menopause Hormonal Treatment Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Menopause Hormonal Treatment Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Menopause Hormonal Treatment Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area and Industry Position
10.1.2 Merck Menopause Hormonal Treatment Models, Specifications and Application
10.1.3 Merck Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Novartis
10.2.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.2.2 Novartis Menopause Hormonal Treatment Models, Specifications and Application
10.2.3 Novartis Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis Company Profile and Main Business
10.2.5 Novartis Recent Developments
10.3 Novo Nordisk
10.3.1 Novo Nordisk Company Information, Head Office, Market Area and Industry Position
10.3.2 Novo Nordisk Menopause Hormonal Treatment Models, Specifications and Application
10.3.3 Novo Nordisk Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novo Nordisk Company Profile and Main Business
10.3.5 Novo Nordisk Recent Developments
10.4 Pfizer
10.4.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.4.2 Pfizer Menopause Hormonal Treatment Models, Specifications and Application
10.4.3 Pfizer Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Pfizer Company Profile and Main Business
10.4.5 Pfizer Recent Developments
10.5 Allergan
10.5.1 Allergan Company Information, Head Office, Market Area and Industry Position
10.5.2 Allergan Menopause Hormonal Treatment Models, Specifications and Application
10.5.3 Allergan Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Allergan Company Profile and Main Business
10.5.5 Allergan Recent Developments
10.6 Emcure Pharmaceuticals
10.6.1 Emcure Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.6.2 Emcure Pharmaceuticals Menopause Hormonal Treatment Models, Specifications and Application
10.6.3 Emcure Pharmaceuticals Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Emcure Pharmaceuticals Company Profile and Main Business
10.6.5 Emcure Pharmaceuticals Recent Developments
10.7 Eli Lilly And Company
10.7.1 Eli Lilly And Company Company Information, Head Office, Market Area and Industry Position
10.7.2 Eli Lilly And Company Menopause Hormonal Treatment Models, Specifications and Application
10.7.3 Eli Lilly And Company Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Eli Lilly And Company Company Profile and Main Business
10.7.5 Eli Lilly And Company Recent Developments
10.8 Cipla
10.8.1 Cipla Company Information, Head Office, Market Area and Industry Position
10.8.2 Cipla Menopause Hormonal Treatment Models, Specifications and Application
10.8.3 Cipla Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Cipla Company Profile and Main Business
10.8.5 Cipla Recent Developments
10.9 Teva Pharmaceutical Industries
10.9.1 Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
10.9.2 Teva Pharmaceutical Industries Menopause Hormonal Treatment Models, Specifications and Application
10.9.3 Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Teva Pharmaceutical Industries Company Profile and Main Business
10.9.5 Teva Pharmaceutical Industries Recent Developments
10.10 Pure Encapsulations, Inc.
10.10.1 Pure Encapsulations, Inc. Company Information, Head Office, Market Area and Industry Position
10.10.2 Pure Encapsulations, Inc. Menopause Hormonal Treatment Models, Specifications and Application
10.10.3 Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Pure Encapsulations, Inc. Company Profile and Main Business
10.10.5 Pure Encapsulations, Inc. Recent Developments
10.11 Bayer
10.11.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.11.2 Bayer Menopause Hormonal Treatment Models, Specifications and Application
10.11.3 Bayer Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Bayer Company Profile and Main Business
10.11.5 Bayer Recent Developments
10.12 Theramex
10.12.1 Theramex Company Information, Head Office, Market Area and Industry Position
10.12.2 Theramex Menopause Hormonal Treatment Models, Specifications and Application
10.12.3 Theramex Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Theramex Company Profile and Main Business
10.12.5 Theramex Recent Developments
10.13 AbbVie
10.13.1 AbbVie Company Information, Head Office, Market Area and Industry Position
10.13.2 AbbVie Menopause Hormonal Treatment Models, Specifications and Application
10.13.3 AbbVie Menopause Hormonal Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 AbbVie Company Profile and Main Business
10.13.5 AbbVie Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|